首页> 外国专利> COMPOSITION FOR PREVENTING AND TREATING LIVER FIBROSIS OR LIVER CIRRHOSIS,CONTAINING, AS ACTIVE INGREDIENT, MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS

COMPOSITION FOR PREVENTING AND TREATING LIVER FIBROSIS OR LIVER CIRRHOSIS,CONTAINING, AS ACTIVE INGREDIENT, MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS

机译:预防和治疗肝纤维化或肝硬化的组合物,其包含作为活性成分的人胚胎干细胞来源的间充质干细胞

摘要

The present invention relates to a composition for preventing and/or treating liver fibrosis or liver cirrhosis, containing, as an active ingredient, mesenchymal stem cells derived from human embryonic stem cells, and particularly, to mesenchymal stem cells derived from human embryonic stem cells which have been ascertained to prevent liver fibrosis, and thus the mesenchymal stem cells derived from human embryonic stem cells can be useful as an active ingredient of a composition or health functional food for protecting the liver, and preventing and treating liver fibrosis or liver cirrhosis.
机译:本发明涉及用于预防和/或治疗肝纤维化或肝硬化的组合物,其含有作为活性成分的源自人胚胎干细胞的间充质干细胞,特别是涉及源自人胚胎干细胞的间充质干细胞,其中已经确定可以预防肝纤维化,因此,源自人胚胎干细胞的间充质干细胞可用作保护肝,预防和治疗肝纤维化或肝硬化的组合物或保健食品的活性成分。

著录项

  • 公开/公告号EP3020405A1

    专利类型

  • 公开/公告日2016-05-18

    原文格式PDF

  • 申请/专利权人 SEOUL NATIONAL UNIVERSITY HOSPITAL;

    申请/专利号EP20140823610

  • 发明设计人 LEE EUN JU;KIM HYO SOO;

    申请日2014-07-04

  • 分类号A61K35/28;A61K35/12;A61P1/16;

  • 国家 EP

  • 入库时间 2022-08-21 14:49:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号